Hims & Hers Health (NYSE:HIMS) Shares Gap Down to $13.22

Hims & Hers Health, Inc. (NYSE:HIMS) gapped down prior to trading on Tuesday . The stock had previously closed at $13.22, but opened at $12.53. Hims & Hers Health shares last traded at $12.66, with a volume of 1,773,677 shares changing hands.

Analysts Set New Price Targets

Several analysts have issued reports on HIMS shares. Jefferies Financial Group reaffirmed a “hold” rating and issued a $15.00 price target (down previously from $17.00) on shares of Hims & Hers Health in a report on Tuesday. SVB Leerink started coverage on shares of Hims & Hers Health in a report on Monday, February 26th. They issued a “market perform” rating and a $10.00 price target on the stock. Citigroup upped their price target on shares of Hims & Hers Health from $12.00 to $16.00 and gave the company a “buy” rating in a report on Tuesday, February 27th. TheStreet raised shares of Hims & Hers Health from a “d” rating to a “c” rating in a report on Monday, March 4th. Finally, Guggenheim upped their price objective on shares of Hims & Hers Health from $15.00 to $17.00 and gave the company a “buy” rating in a research note on Tuesday, February 27th. Five equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $14.85.

Hims & Hers Health Price Performance

The firm’s 50-day moving average price is $13.30 and its 200-day moving average price is $9.72. The company has a market cap of $2.71 billion, a price-to-earnings ratio of -113.82 and a beta of 0.91.

Hims & Hers Health (NYSE:HIMS) last released its quarterly earnings results on Monday, February 26th. The company reported $0.01 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.03. The business had revenue of $246.60 million during the quarter, compared to analyst estimates of $245.84 million. Hims & Hers Health had a negative net margin of 2.70% and a negative return on equity of 7.21%. The business’s revenue was up 47.4% on a year-over-year basis. During the same period last year, the business earned ($0.05) EPS. On average, sell-side analysts anticipate that Hims & Hers Health, Inc. will post 0.1 earnings per share for the current year.

Insider Activity at Hims & Hers Health

In other Hims & Hers Health news, insider Soleil Boughton sold 22,839 shares of the firm’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $10.03, for a total transaction of $229,075.17. Following the completion of the transaction, the insider now directly owns 154,345 shares of the company’s stock, valued at approximately $1,548,080.35. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other Hims & Hers Health news, insider Soleil Boughton sold 22,839 shares of the firm’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $10.03, for a total transaction of $229,075.17. Following the completion of the transaction, the insider now directly owns 154,345 shares of the company’s stock, valued at approximately $1,548,080.35. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Irene Becklund sold 2,747 shares of the firm’s stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $12.08, for a total transaction of $33,183.76. Following the completion of the transaction, the insider now owns 5,494 shares in the company, valued at $66,367.52. The disclosure for this sale can be found here. In the last three months, insiders sold 673,335 shares of company stock valued at $8,452,208. Corporate insiders own 31.63% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of HIMS. Swiss National Bank lifted its position in Hims & Hers Health by 7.9% in the 1st quarter. Swiss National Bank now owns 185,000 shares of the company’s stock valued at $986,000 after purchasing an additional 13,500 shares during the last quarter. Citigroup Inc. lifted its position in Hims & Hers Health by 249.9% in the 1st quarter. Citigroup Inc. now owns 34,718 shares of the company’s stock valued at $185,000 after purchasing an additional 24,796 shares during the last quarter. Ergoteles LLC bought a new stake in Hims & Hers Health in the 1st quarter valued at about $949,000. Charles Schwab Investment Management Inc. lifted its position in Hims & Hers Health by 2.5% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 616,214 shares of the company’s stock valued at $3,285,000 after purchasing an additional 14,990 shares during the last quarter. Finally, Northern Trust Corp lifted its position in Hims & Hers Health by 1.3% in the 1st quarter. Northern Trust Corp now owns 253,307 shares of the company’s stock valued at $1,350,000 after purchasing an additional 3,226 shares during the last quarter. 63.52% of the stock is currently owned by institutional investors.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.